Breaking barriers

Researchers led by Michael Mitchell (left) and Ph.D. candidate Emily Han of the School of Engineering and Applied Science have modified lipid nanoparticles, the revolutionary technology behind the COVID-19 mRNA vaccines, to not only cross the blood-brain barrier but also target specific types of cells, including neurons. This breakthrough marks a significant step toward potential next-generation treatments for neurological diseases like Alzheimer’s and Parkinson’s.